US 8465767
Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles
granted A61KA61K9/2027A61K9/2846
Quick answer
US patent 8465767 (Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles) held by TAKEDA GMBH expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TAKEDA GMBH
- Grant date
- Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K9/2027, A61K9/2846, A61P, A61P1/00